The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

A Study of YL202 in Patients With Advanced Solid Tumors

Phase 2 · 100 people · 1 site in China · Recruiting now

August 11, 2026
Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Phase 2 · 210 people · 1 site in China · Recruiting now

August 11, 2026
Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer

Not phased · randomised · 254 people · 9 sites in Sweden · Recruiting now

August 11, 2026
AB122 Platform Study

Phase 1 · 917 people · 9 sites in Japan · Recruiting now

August 11, 2026
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Phase 2 · 40 people · 20 sites in 10 countries · Recruiting now

August 11, 2026
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Phase 1 · 108 people · 18 sites in United States · Recruiting now

August 11, 2026
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Phase 2 · 70 people · 1 site in United States · Recruiting now

August 11, 2026
BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Phase 1 · 665 people · 17 sites in 2 countries · Recruiting now

August 11, 2026
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Phase 1 · 364 people · 20 sites in 4 countries · Recruiting now

August 11, 2026
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Phase 2 · randomised · 97 people · 2 sites in United States · Recruiting now

August 11, 2026